Answers are grounded in this paper and cite their sources.
Despite the numerous uses of chitin and chitosan as new functional materials of high potential in various fields, they are still behind several directly compressible excipients already dominating pharmaceutical applications. There are, however, new attempts to exploit chitin and chitosan in co-processing techniques that provide a product with potential to act as a direct compression (DC) excipient. This review outlines the compression properties of chitin and chitosan in the context of DC pharmaceutical applications.
No takes yet. Share an insight, caveat, or question.
Badwan et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: